Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001702956-18-000001
Filing Date
2018-08-30
Accepted
2018-08-30 17:00:48
Documents
1
Effectiveness Date
2018-08-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10741
  Complete submission text file 0001702956-18-000001.txt   11780
Mailing Address 161 E MICHIGAN AVE, SUITE 400 KALAMAZOO MI 49007
Business Address 161 E MICHIGAN AVE, SUITE 400 KALAMAZOO MI 49007 269-343-6732
Cirius Therapeutics, Inc. (Filer) CIK: 0001702956 (see all company filings)

EIN.: 820928811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-320445 | Film No.: 181047756